Non-alcoholic fatty liver disease is the most common cause of chronic liver injury. After 4 weeks of CoQ10 supplementation, waist circumference and serum AST concentrations were significantly decreased as compared to the placebo-treated group. The study showed a potential for CoQ10 therapy in improving serveral anthropometric and biochemical variables in non-alcoholic fatty liver disease. Longer studies with higher doses of CoQ10 are required to further evaluate this potential benefit.
Here is the link to the entire article:
God bless you and to your good health!
Joyce Gibb MS, CRNP
Ask The Pharmacist Group, LLC